Hidden sodium in effervescent-tablet dietary supplements and over-the-counter drugs: a comparative cross-sectional study
Open Access
Abstract
Objective Dietary sodium intake represents a risk factor for cardiovascular disease and mortality. The study sought to analyse the sodium content of effervescent dietary supplements and drugs in Germany and the USA. Design Comparative cross-sectional study. Setting and methods The sodium content of 39 dietary supplement effervescent tablets available in Germany was measured in May and June 2022 using optical emission spectrometry with inductively coupled argon plasma. The sodium content of 33 common pharmacy-only effervescent tablets (over-the-counter (OTC) drugs) in Germany was obtained from the summary of product characteristics. We compared the sodium content of the measured German dietary supplement effervescent tablets to that of 51 dietary supplement effervescent tablets available in the USA (data: National Institutes of Health’s Dietary Supplement Label Database). Results The measured sodium content in the German dietary supplements was 283.9±122.6 mg sodium/tablet, equivalent to 14±6% of the maximum recommended daily sodium intake (MRDSI). Vitamin products had the highest (378.3±112.8 mg, 19±6% of MRDSI), and calcium products had the lowest mean sodium content (170.4±113.2 mg, 9±6% of MRDSI). Vitamin products contained significantly more sodium than magnesium (378.3 mg vs 232.7 mg; p=0.004), calcium (378.3 mg vs 170.4 mg; p=0.006) and mineral products (378.3 mg vs 191.6 mg; p=0.048). The sodium content measured in products available in Germany was higher when compared with the declared sodium content on the label of the products sold in the USA (283.9 mg vs 190.0 mg; pConclusion Effervescent tablets of nutritional supplements and OTC drugs contain high amounts of sodium, which often is not disclosed.Keywords
This publication has 29 references indexed in Scilit:
- Nutrition: Vitamins on trialNature, 2014
- Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwideBMJ Open, 2013
- Association between cardiovascular events and sodium-containing effervescent, dispersible, and soluble drugs: nested case-control studyBMJ, 2013
- A systematic review of the effect of paracetamol on blood pressure in hypertensive and non‐hypertensive subjectsBritish Journal of Clinical Pharmacology, 2012
- Reduced Dietary Salt for the Prevention of Cardiovascular Disease: A Meta-Analysis of Randomized Controlled Trials (Cochrane Review)American Journal of Hypertension, 2011
- Salt reduction lowers cardiovascular risk: meta-analysis of outcome trialsThe Lancet, 2011
- Nutrition in cardiovascular disease: salt in hypertension and heart failureEuropean Heart Journal, 2011
- Projected Effect of Dietary Salt Reductions on Future Cardiovascular DiseaseNew England Journal of Medicine, 2010
- Salt intakes around the world: implications for public healthInternational Journal of Epidemiology, 2009
- Blood pressure reduction in hypertensive patients after withdrawal of effervescent medicationPharmacoepidemiology and Drug Safety, 2009